News and Document archive source
copyrighted material disclaimer at bottom of page

NewsMinenature-healthhealth — Viewing Item

Depression pills { May 7 2002 }

Original Source Link: (May no longer be active)

Against Depression, a Sugar Pill Is Hard to Beat
Placebos Improve Mood, Change Brain Chemistry in Majority of Trials of Antidepressants

By Shankar Vedantam
Washington Post Staff Writer
Tuesday, May 7, 2002; Page A01

After thousands of studies, hundreds of millions of prescriptions and tens of billions of dollars in sales, two things are certain about pills that treat depression: Antidepressants like Prozac, Paxil and Zoloft work. And so do sugar pills.

A new analysis has found that in the majority of trials conducted by drug companies in recent decades, sugar pills have done as well as -- or better than -- antidepressants. Companies have had to conduct numerous trials to get two that show a positive result, which is the Food and Drug Administration's minimum for approval.

What's more, the sugar pills, or placebos, cause profound changes in the same areas of the brain affected by the medicines, according to research published last week. One researcher has ruefully concluded that a higher percentage of depressed patients get better on placebos today than 20 years ago.

Placebos -- or dud pills -- have long been used to help scientists separate the "real" effectiveness of medicines from the "illusory" feelings of patients. The placebo effect -- the phenomenon of patients feeling better after they've been treated with dud pills -- is seen throughout the field of medicine. But new research suggests that the placebo may play an extraordinary role in the treatment of depression -- where how people feel spells the difference between sickness and health.

The new research may shed light on findings such as those from a trial last month that compared the herbal remedy St. John's wort against Zoloft. St. John's wort fully cured 24 percent of the depressed people who received it, and Zoloft cured 25 percent -- but the placebo fully cured 32 percent.

The confounding and controversial findings do not mean that antidepressants do not work. But clinicians and researchers say the results do suggest that Americans may be overestimating the power of the drugs, and that the medicines' greatest benefits may come from the care and concern shown to patients during a clinical trial -- a context that does not exist for millions of patients using the drugs in the real world.

"The drugs work, and I prescribe them, but they are not what they are cracked up to be," said Wayne Blackmon, a Washington psychiatrist whose practice largely comprises patients who suffer from depression. "I know from clinical experience the drugs alone don't do the job."

Still, drugs may have become the reflexive treatment for the vast majority of Americans receiving medical attention for depression: As the number of doctor visits for depression rose from 14 million in 1987 to almost 25 million last year, medications were prescribed for nine in 10 patients, according to research published last week.

It is not clear how many patients received medicines in a context of therapy, although research has indicated that combining medicines with psychotherapy produces the best results.

But Randall Stafford, the Stanford University physician who conducted the study on doctor visits, found that less than one-third of them in 2001 were to psychiatrists and two-thirds of them were to primary care physicians. The former are more likely to situate the medicines in a larger context of therapy, while the latter are less knowledgeable about therapy, more pressed for time and less likely to offer patients anything like the attention they would receive in a clinical trial.

The average participant in an eight-week trial spends about 20 hours being examined by top experts and highly trained caregivers, said Seattle psychiatrist Arif Khan, who studied the placebo effect in trials submitted to the FDA. Participants -- including those being given sugar pills -- are asked detailed questions about how they are feeling, and their every psychological change is closely noted.

In comparison, Khan noted, the average patient with depression sees a doctor perhaps 20 minutes a month.

His analysis of 96 antidepressant trials between 1979 and 1996 showed that in 52 percent of them, the effect of the antidepressant could not be distinguished from that of the placebo. Khan said the makers of Prozac had to run five trials to obtain two that were positive, and the makers of Paxil and Zoloft had to run even more. He analyzed trials that were made public in the medical literature, which tend to show positive results, and those that were not.

"It speaks to the difficulty we have in classifying and identifying the disorders we deal with," said Thomas Laughren, who heads the group of scientists at the FDA that evaluates the medicines. "Psychiatric diagnosis is descriptive. We don't really understand psychiatric disorders at a biological level."

Patients with similar symptoms, he explained, may have different problems with their brain chemistry. Scientists don't understand the neural mechanisms of depression -- or why medicines like Prozac and Paxil work.

"We like to think we give people treatments and they get better," said Andrew Leuchter, a professor of psychiatry at UCLA. "We have this fallacy of success, but we don't know in any individual why they get better. Undoubtedly one of those factors is the time we spend with people and the connectedness that gives patients."

In January, Leuchter published a study in the American Journal of Psychiatry, in which he tracked some of the brain changes associated with drugs such as Prozac and Effexor, which are called selective serotonin reuptake inhibitors. When Leuchter compared the brain changes in patients on placebos, he was amazed to find that many of them had changes in the same parts of the brain that are thought to control important facets of mood.

Patients who got better on placebos showed heightened activity in the prefrontal lobe, and that activity continued to rise during the eight weeks of the study. Those who responded to medicine initially showed a decline in prefrontal brain activity, then a rise that eventually tapered off. Thirty-eight percent of patients responded to the placebo, and 52 percent to the medicines.

Once the trial was over and the patients who had been given placebos were told as much, they quickly deteriorated. People's belief in the power of antidepressants may explain why they do well on placebos. Patients in trials are not told which they are receiving.

Likewise, sea changes in the treatment of depression -- including the reduction in the stigma attached to mental illness, the widespread use of antidepressants and the immense marketing efforts by their manufacturers -- may explain why Timothy Walsh, a psychiatrist at Columbia University, recently found that the placebo effect has grown in recent years. He found that greater percentages of people tended to get better on placebos during trials of antidepressants in 2000 than in 1981.

Some observers assert that the medicines themselves work because of the placebo effect, but most psychiatrists believe the drugs do have an effect of their own. Drugs are a "placebo-plus" treatment, said Helen Mayberg, head of neuropsychiatry at the Rotman Research Institute at the University of Toronto.

In a study published last week in the American Journal of Psychiatry, Mayberg evaluated brain changes during trials using a sophisticated brain imaging technique. She found that medicines, besides working on areas that are activated by placebos, also work on areas deep in the brain stem, the hippocampus and striatum.

1 in 3 americans have high blood pressure
1 in 3 kids 00 develop diabetes { June 15 2003 }
12 dangerous dietary supplements
Acupuncture helps arthritic knees
Alzheimers cases top 13m by 2050 { August 19 2003 }
Americans searching for pain relief { May 9 2005 }
Americans sicker than brits with more on health care { May 3 2006 }
Americans want universal health care
Antidepressants linked suicides { October 27 2003 }
Antioxidant rich foods preserve vision
Avoid drugs for migraine relief { May 4 2006 }
Beef business creates anti vegan study { February 21 2005 }
Black health worst condition { October 12 2003 }
Bran diet lowers risk of heart disease
Breastfeeding fights arthritis
Breastfeeding fights diabetes in mother
Britain leads the world in anti depressants
Britiain US worst western nations for children
Burger king down
Carpal tunnel from mouse not keyboard { June 17 2003 }
Chlorine in pools damages lungs
Cholesterol drugs not having effect
Cholesterol inhibitors in garlic identified
Chopsticks can be harmful
Dangerous dietary supplements { April 7 2004 }
Dark chocolate aids blood flow { August 29 2004 }
Dark chocolate health benefits { June 1 2004 }
Depression pills { May 7 2002 }
Doctors calls for national health insurance { August 12 2003 }
Doctors rally around universal health care
Drinking can shrink the brain { December 8 2003 }
Excercise generates new stem cells and vessels { September 5 2007 }
Exercise helps elderly mental sharpness
Exercise helps the brain work better
Facts on soy { April 13 2004 }
Faster aging with obesity and smoking { June 15 2005 }
Fats not increase stroke risk { October 3 2003 }
Federal warning on tuna mercury danger { December 11 2003 }
Fiber benefit found { May 2 2003 }
Floride linked low iq { August 25 2003 }
Garlic study may give herb a boost
German doctor cures aids with garlic and olive oil { November 29 2005 }
Girls meat milk dioxin warning
Green tea may prevent hiv { November 10 2003 }
Headphones use causes hearing loss
Heavy lifting protects heart
Heavy social drinkers show brain damage
High blood pressure up { July 9 2003 }
High lead found in boston water { April 28 2004 }
Hormone treated beef is dangerous to human health { October 16 2003 }
Hospital tries to remove mcdonalds from premises
Indians heart attack
Irradiated meat
Lead scare prompts EPA review of rules { July 23 2004 }
Loud music can damage lungs
Mcdonalds closes 175 { November 8 2002 }
Mcdonalds fries contain potential allergens
Mcdonalds lawsuit dismissed { January 22 2003 }
Mcdonalds lied again about its french fries
Mcdonalds meat fries { May 24 2001 }
Mcdonalds trans acids
Medical injuries kill 32000 annually
Milk and redmeat inflamation { September 29 2003 }
More evidence vegetarian diet may stop cancer
Ms vd
Neurologist helps people understand migraine triggers { April 27 2006 }
New study says slouching is better sitting
Nine heart risk factors { August 30 2004 }
Pills no proven to provide benefits from vegetables
Prozac may stunt growing bones
Salmon dye must be labeled { May 2 2003 }
Salmonella [pdf]
Sanitation is greatest medical milestone { January 18 2007 }
Seeds of dementia sown in midlife health diet lifestyle
Soy best for lowering cholesterol
Soy thyroid function
Stress can cause common cold or cancer
Study links drinking brain tissue loss
Supplements work
Survey finds millions new drug abusers
Sushi tuna found to have dangerous mercury levels { January 23 2008 }
Toddlers tv watching linked to attention deficit { April 5 2004 }
Tomato juice may stave off heart troubles { August 22 2004 }
Toxic mercury in environment causing autism { March 17 2005 }
Trans fats worse saturated fats { July 9 2003 }
Uncooked foods healthier { July 17 2000 }
Us health care spending surges again { January 9 2004 }
Vegan sues mcdonalds over french fries again { February 17 2006 }
Vitamins and calcium help pms symptons { June 17 2005 }
Watching TV causes hormone imbalance { June 28 2004 }
Wifi may endanger childrens health { April 22 2007 }

Files Listed: 91


CIA FOIA Archive

National Security
Support one-state solution for Israel and Palestine Tea Party bumper stickers JFK for Dummies, The Assassination made simple